Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes   Bogaards Johannes A  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite

Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

By Du Juan   Näsman Anders   Carlson Joseph W.   Ramqvist Torbjörn   Dalianis Tina  

Acta Oncologica, Vol. 50, Iss. 8, 2011-11 ,pp. : 1215-1219

Informa Healthcare

Access to resources Recommend Favorite

Human Papillomavirus Testing in Primary Screening for Cervical Cancer of Human Immunodeficiency Virus-Infected Women, 1990-1998

By Petry K.U.   Bohmer G.   Iftner T.   Flemming P.   Stoll M.   Schmidt R.E.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 427-431

Elsevier

Access to resources Recommend Favorite

Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients

By Silins I.   Avall-Lundqvist E.   Tadesse A.   Jansen K.U.   Stendahl U.   Lenner P.   Zumbach K.   Pawlita M.   Dillner J.   Frankendal B.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 333-338

Academic Press

Access to resources Recommend Favorite

Detection of human papillomavirus and expression of osteopontin in cervical cancer specimens

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 447-453

Spandidos Publications

Access to resources Recommend Favorite